Trading Update
| Stock | Austco Healthcare Ltd (AHC.ASX) | 
|---|---|
| Release Time | 29 Oct 2025, 9:22 a.m. | 
| Price Sensitive | Yes | 
Austco Healthcare reports 51% revenue growth in Q1 FY26
- Revenue of $23.2 million, up 51% on prior corresponding period
 - EBITDA margin increased to 18.1% from 16.0% at FY25 year-end
 - Unfilled Contracted Revenue of $54.6 million at 23 October 2025
 
Austco Healthcare Limited (ASX: AHC) has provided a trading update for the first quarter of the 2026 financial year, reflecting another period of strong growth and operational execution across the business. The company reported revenue of $23.2 million, up 51% on the prior corresponding period, which includes both organic and inorganic growth. EBITDA reached $4.2 million, representing an 18.1% EBITDA margin, up from 16.0% at the end of FY25. Austco's Unfilled Contracted Revenue (UCR) stood at $54.6 million as of 23 October 2025, providing a strong foundation for continued revenue momentum. The improvement in profitability reflects strong organic growth, positive contributions from recent acquisitions, and the benefits of disciplined operating leverage as integration and efficiency gains continue to flow through earnings. Operationally, Austco continues to benefit from strong demand for its integrated nurse call, RTLS, and workflow solutions, with a robust sales pipeline across its core healthcare markets, supported by increasing interest in its innovative, integrated product suite.
Austco is positioned to sustain profitable growth through FY26 and beyond, targeting 10-14% organic revenue growth for the financial year.
With strong demand, integrated solutions, and continued efficiency gains supporting earnings growth, Austco is well-positioned to deliver continued growth and disciplined execution through FY26 and beyond.